• Corpus ID: 8579895

Treatment of hypothyroidism.

  title={Treatment of hypothyroidism.},
  author={William J Hueston},
  journal={American family physician},
  volume={64 10},
  • W. Hueston
  • Published 15 November 2001
  • Medicine, Biology
  • American family physician
Thyroid disease affects up to 0.5 percent of the population of the United States. Its prevalence is higher in women and the elderly. The management of hypothyroidism focuses on ensuring that patients receive appropriate thyroid hormone replacement therapy and monitoring their response. Hormone replacement should be initiated in a low dosage, especially in the elderly and in patients prone to cardiac problems. The dosage should be increased gradually, and laboratory values should be monitored… 

Figures and Tables from this paper

Comparative Clinical Study to Evaluate the Efficacy of an Herbal Drug with Thyroxine in the Management of Primary Hypothyroidism
A clinical study to evaluate the efficacy of an herbal drug with thyroxine in the management of primary hypothyroidism was designed, and a herbal drug Commiphora mukul (Muqil) which has shown positive thyroid activities in experimental animals was selected to check its comparative efficacy with Thyroxine.
Timing of Thyroxine Dose Adjustment in Hypothyroid Patients: When are TSH Levels Stable?
Dose changes can be made after 4 weeks of treatment, longer periods are unnecessary and TSH did not change significantly after a mean of 3.5 weeks after the introduction of thyroxine.
Management of hypothyroidism in adults.
  • N. Tandon
  • Medicine
    The Journal of the Association of Physicians of India
  • 2011
Widespread screening is unlikely to be cost-effective and given the non-specific symptoms of hypothyroidism, many patients will nevertheless be tested, however, asymptomatic screening should not be confused with this practice.
Overt and Subclinical Hypothyroidism
Limited evidence suggests that treatment of subclinical hypothyroidism in patients with serum TSH of up to 10 mIU/L should probably be avoided in those aged >85 years, and over-replacement is common in clinical practice and is associated with increased risk of atrial fibrillation and osteoporosis, and hence should be avoided.
  • H. Baskin, R. Cobin, J. Tourtelot
  • Medicine, Biology
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2002
These clinical practice guidelines summarize the recommendations of the American Association of Clinical Endocrinologists for the diagnostic evaluation of hyperthyroidism and hypothyroidism and for
Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Individualised conditionally defined setpoints may provide appropriate biochemical targets to be clinically tested, together with a stronger focus on clinical presentation and future endpoint markers of tissue thyroid state.
Hypothyroidism: current state of the problem
Doping difficulties are discussed, as hypothyroidism disrupts the functioning of most organs and systems of the body (musculoskeletal, cardiovascular, urinary, gastrointestinal, central and peripheral nervous systems) and can be masked by various diseases.
Profound Hypothyroidism—A Clinical Review with Eight Recent Cases: Is It Right Before Our Eyes?
This review will focus on the panorama of manifestations of profound hypothyroidism, update clinicians on diagnosis and management of severe disease, and feature eight illustrative cases.
Guidelines for the Postoperative Treatment of Thyroid Cancer: Levothyroxine and Calcium/Vitamin D Supplements
Thyroid hormone replacement is required after surgery for thyroid cancer to manage postoperative hypothyroidism and for thyroid-stimulating hormone (TSH) suppression therapy. However, considering the


Thyroid disease.
  • T. Evans
  • Medicine, Biology
    Primary care
  • 2003
The aging thyroid. The use of thyroid hormone in older persons.
In chronic users of thyroid hormone, it is important to review currently appropriate indications and to measure serum thyrotropin levels to assess the adequacy of treatment of primary hypothyroidism.
The syndromes of resistance to thyroid hormone.
This review of syndromes of resistance to thyroid hormone summarizes all cases known to us, presents their common features as well as unusual manifestations, and presents the expected metabolic responses in the peripheral tissues.
L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism.
  • A. Pines, I. Dotan, D. Ayalon
  • Medicine, Biology
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 1999
Taking as a whole, the hypothyroid women had a non-significant higher baseline bone mineral density (BMD) as compared to the euthyroid controls, which prevented the beneficial effect of HRT on BMD.
Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians.
Office-based screening to detect overt thyroid dysfunction may be indicated in women older than 50 years of age and large randomized trials are needed to determine the likelihood that treatment will improve quality of life in otherwise healthy patients who have mildly elevated TSH levels.
The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly.
Of 344 relatively healthy persons older than 60 years, 22 (5.9%) had a clearly elevated level of serum thyrotropin (TSH) (greater than 10 muU/mL), a finding more common in women than in men. Ten of
Drugs and thyroid function.
Testing of thyroid function is common in clinical practice. Many patients who are tested, including those who have or are receiving treatment for thyroid disease, take medications that may affect
Normalization of Hyperhomocysteinemia with l-thyroxine in Hypothyroidism
It is hypothesized that l-thyroxine treatment would normalize homocysteine levels in hypothyroid patients, and a prospective cohort study to test this hypothesis was conducted.
Treatment of hypothyroidism with once weekly thyroxine.
During weekly T4 administration, autoregulatory mechanisms maintain near-euthyroidism, and a slightly larger dose than 7 times the normal daily dose may be required for complete biochemical euthyroidistan.
Levothyroxine replacement dose for primary hypothyroidism decreases with age.
The data indicate that thyroxine requirement may decrease continuously with age, which probably reflects the progressive decrease in Thyroxine degradation rate that occurs with age.